Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Stern

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Molecular Cell|June 7, 2002
Rad9 phosphorylation sites couple Rad53 to the Saccharomyces cerevisiae DNA damage checkpointMarc F Schwartz, Jimmy K Duong, Zhaoxia Sun, et al.
Pigment Cell & Melanoma Research|April 27, 2013
MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXLKathryn A Tworkoski, James T Platt, Antonella Bacchiocchi, et al.
Plos One|November 27, 2013
Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment methodYalai Bai, Huan Cheng, Jennifer Bordeaux, et al.
Molecular Systems Biology|March 26, 2021
Identifying modules of cooperating cancer driversMichael I Klein, Vincent L Cannataro, Jeffrey P Townsend, et al.
Oncotarget|August 27, 2019
Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancerSierra A Colavito, James T Platt, Matthew A Held, et al.
The Journal of Investigative Dermatology|June 11, 2017
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein SynthesisNicholas Theodosakis, Goran Micevic, Casey G Langdon, et al.
Molecular Cancer Research : MCR|May 16, 2014
Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cellsVikram B Wali, Jonathan W Haskins, Maureen Gilmore-Hebert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patientsMichael P DiGiovanna, David F Stern, Susan M Edgerton, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
ErbB2 is required for ductal morphogenesis of the mammary glandAmy J Jackson-Fisher, Gary Bellinger, Rajani Ramabhadran, et al.
Cancer Research|June 25, 2013
EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasisJerrica L Breindel, Jonathan W Haskins, Elizabeth P Cowell, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Molecular Cell|June 7, 2002
Rad9 phosphorylation sites couple Rad53 to the Saccharomyces cerevisiae DNA damage checkpointMarc F Schwartz, Jimmy K Duong, Zhaoxia Sun, et al.
Pigment Cell & Melanoma Research|April 27, 2013
MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXLKathryn A Tworkoski, James T Platt, Antonella Bacchiocchi, et al.
Plos One|November 27, 2013
Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment methodYalai Bai, Huan Cheng, Jennifer Bordeaux, et al.
Molecular Systems Biology|March 26, 2021
Identifying modules of cooperating cancer driversMichael I Klein, Vincent L Cannataro, Jeffrey P Townsend, et al.
Oncotarget|August 27, 2019
Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancerSierra A Colavito, James T Platt, Matthew A Held, et al.
The Journal of Investigative Dermatology|June 11, 2017
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein SynthesisNicholas Theodosakis, Goran Micevic, Casey G Langdon, et al.
Molecular Cancer Research : MCR|May 16, 2014
Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cellsVikram B Wali, Jonathan W Haskins, Maureen Gilmore-Hebert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patientsMichael P DiGiovanna, David F Stern, Susan M Edgerton, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
ErbB2 is required for ductal morphogenesis of the mammary glandAmy J Jackson-Fisher, Gary Bellinger, Rajani Ramabhadran, et al.
Cancer Research|June 25, 2013
EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasisJerrica L Breindel, Jonathan W Haskins, Elizabeth P Cowell, et al.
Pageof 8